Interdisciplinary Treatment Grants

Chair and Co-Chair of the Interdisciplinary Treatment Grants Review Panel:

• Professor Michelle Garrett, Current Chair of our Scientific Advisory Board (SAB), Professor of Cancer Therapeutics, University of Kent, UK
• Dr Stephanie Dougan, Assistant Professor, Microbiology and Immunobiology, Dana Farber Cancer Institute, Boston, US

Technical Panel Members:

• Professor Seth Coffelt, Junior Group Leader, CRUK Scotland Institute, Glasgow, UK
• Professor Tony Hollingsworth, Associate Director for Basic Research, University of Nebraska, USA
• Dr Laura Wood, Associate Professor of Pathology & Oncology, Johns Hopkins University School of Medicine, Baltimore, USA
• Dr Nelson Dusetti, Director of Research Pancreatic Cancer Team, Cancer Research Centre of Marseille, France
• Mr Richard Jackson, Medical Statistician, University of Liverpool, UK

Lay Panel Members:

• Angela Donkin, Member of our Scientific Advisory Board (SAB), UK
• Joanna Allison, Member of our Scientific Advisory Board (SAB), UK

Eligible applicants include:

• Clinical and non-clinical researchers.
• Projects must have a minimum of two Principal Investigators (Lead and Co-Applicant or two Co-Leads) from distinct disciplines, with at least one PI working in pancreatic cancer research. One PI must also be UK-based and designated as the Host Institution for contractual and financial purposes.
• Researchers from the same institution, but from more than one specialism, would be considered interdisciplinary.
• International collaborations and/or those with commercial organisations are welcome.
• Applicants may have worked together previously, but not in the interdisciplinary manner indicated in this proposal.

Alternatively, applicants may have worked together previously in a similar interdisciplinary manner, but not focused on pancreatic cancer.

• Open for applications: 1st February 2024
• Application deadline: 1pm, Thursday 13th June 2024
• Interviews: October 2024
• Funding decisions: December 2024

All applicants are strongly encouraged to refer to the Letter of Intent Template, Full application Guidance and FAQs before completing their application.

All potential applicants and their Host Institutions should ensure that they have also reviewed Pancreatic Cancer UK’s Terms and Conditions, which set out the standard terms applicable to the Interdisciplinary Treatment Grants funded by Pancreatic Cancer UK.

Applicants should be aware that their proposals will also be reviewed by people with lived experience of pancreatic cancer and are therefore strongly encouraged to demonstrate how they have already/intend to involve people with lived experience in the development and delivery of their work. At Pancreatic Cancer UK, we have a fantastic Research Involvement Network (RIN) made up of over 500 individuals that have been affected by pancreatic cancer including patients, carers, loved ones and survivors. They give valuable insight and help to ensure that research is centred around the needs of patients. If you would like members of RIN to help shape your application you can find out more about how to do this here. Please get in touch with the Research Team as soon as possible if you would like to discuss this further or if you have any questions.

To apply, please submit your Letter of Intent to research@pancreaticcancer.org.uk this is a compulsory step to applying for the Interdisciplinary Treatment Grants.

The review process will consist of three phases: a letter of intent submission, a full application, and an interview.

Letter of Intent Template

Full application Guidance

FAQs

Terms and Conditions